Home
Omniome

Omniome Market Share Analysis for June 2026

The only provider of highly accurate long-read and short-read technology to address genomic complexity with exceptional accuracy

Jobs and Career > Human Resources

Domainomniome.com

Year Founded2013

Employees51 - 200

Annual Revenue$25M - $50M

Omniome

Omniome (including company regionals)

omniome.com

See more website traffic and engagement information

Omniome Revenue up to June 2026 is 25M - 50M

revenue generated by Omniome top domains

Omniome top domains revenue over 3 years

Revenue for Omniome top domains

omniome.com25M - 50M

See more with Sales Intelligence

Total visits to Omniome's top domains

Understand Omniome market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Omniome's top domains

Analyze Omniome engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Omniome's top domains

See how Omniome keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Omniome top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Omniome

These are the website technologies, by industry, used by Omniome top domains

Advertising (7)

DoubleClick

Email Services (3)

G Suite

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Omniome

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

Newspacb.com acquired Omniome for $800M on Sep 20th '21.Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based biotechnology company developing a proprietary and highly differentiated short-read sequencing platform capable of delivering increased sequencing accuracy, announced today the companies have closed the transaction under which Pacific Biosciences acquired Omniome.

NewsPacific Biosciences acquired Omniome for $800M on Jan 1st '21.Pacific Biosciences said on Tuesday that it has signed a definitive agreement to acquire Omniome, a short-read sequencing technology developer, for up to $800 million.

NewsPacbio acquired Omniome for $800M on Oct 25th '21.The expansion of the collaboration is expected to add the short read sequencing technology enabled by Sequencing by Binding (SBB) chemistry upon close of PacBio’s proposed acquisition of Omniome, and contingent upon PacBio’s and Invitae’s agreement of associated terms.